Fuelling Workouts on GLP-1 Medications Safely Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and liraglutide are transforming diabetes and weight management, but their appetite-suppressing effects pose unique challenges for active individuals
2021, cited below)
This allows for more frequent, high-quality training sessions and reduces the risk of overtraining
What are your baseline (first f/u appointment) goals for patient education when initiating this new medication therapy
In Miami Beach, Florida, there are many great benefits of losing weight that make the hard work you put into getting healthy worth it
In endothelial cell models, BPC-157 enhanced ERK1/2 phosphorylation in a dose-dependent manner, increasing cellular proliferation, migration, and vascular tube formation via downstream transcription factors c-Fos, c-Jun, and EGR-1